The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|61|4|217-222

ISSN： 0009-3157

Source： Chemotherapy, Vol.61, Iss.4, 2016-02, pp. : 217-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Glasgow Prognostic Score Is a Good Predictor of Treatment Outcome in Patients with Unresectable Pancreatic Cancer

By  

Chemotherapy, Vol. 56, Iss. 6, 2010-11 ,pp. : 501-506

Karger

Access to resources Recommend Favorite

Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015

By  

Chemotherapy, Vol. 62, Iss. 5, 2017-06 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

By Ahn Sung Gwe   Lee Hak Min   Lee Hak Woo   Lee Seung Ah   Lee Se-Ra   Leem Sun-Hee   Jeong Joon   Chu In-Sun  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 23685-23699

MDPI

Access to resources Recommend Favorite

Cisplatin plus Gemcitabine Chemotherapy in Taxane/Anthracycline-Resistant Metastatic Breast Cancer

By  

Chemotherapy, Vol. 55, Iss. 3, 2009-04 ,pp. : 155-160

Karger

Access to resources Recommend Favorite